1000 Proteins to Unlock the Proteome

Delivering Affordable, Scalable, and Quantitative Proteomics.

May 13 | 11:00 AM ET

Anatomy of the nELISA Platform

Leveraging groundbreaking technology to build an ecosystem of tools, modalities, and services to dramatically expand access to the proteome.

nELISA Technology

Using DNA nanotechnology, we transformed the ELISA into a high-throughput proteomics technology.

nELISA Targets

~275 cytokines on-boarded to-date for comprehensive profiling of the immune secretome.

nELISA Service

The world’s fastest & most seamless protein profiling service, with as fast as 1-week turnaround.

Solid blue gradient background with deep indigo to bright blue colors

Multiplexing without compromise

The nELISA is designed to achieve multiplexing at-scale without the usual trade-offs.

High Throughput

At 10,000+ samples per week per workcell, nELISA brings central lab-throughput to proteomics.

True Multiplexing

A complete and elegant solution to the cross-reactivity problem in multiplexed immunoassays.

Flexible Multiplexing

Replacing fixed, incompatible panels with the freedom to pick proteins “à la carte”.

Multimodal

Enabling the study of protein expression, interaction, or modification, in one platform.

Quantitative Profiling

Broad profiling meets absolute quantification, delivering consistent precision with <10% intra-lot CV.

Cost Effective

Enabled by innovation, the nELISA brings about unparalleled cost efficiency.

Solid navy blue background with no distinguishing features

Transforming Discovery.
Validated by Visionaries.

“The nELISA has transformed our capabilities and is the primary data stream for our high throughput in vitro and ex vivo experiments. The data dimensionality, quality and turnaround time far surpasses anything we could achieve in house ourselves.”
Sarah Headland
Associate Director, Myeloid Biology @ Immunai
“Understanding and creating learning models to accelerate drug discovery is challenging. Nomic's nELISA platform allows us to understand, in an unbiased way; proteomics in relation to phenomics.”
Dale Wright
VP Biology @ Recursion Pharmaceuticals
“The nELISA platform helped us examine our immune assays in more depth, and greater sample number. This greatly opened up what we can see in a complex immune assay, giving us a much better understanding and allowing us to reach conclusions much faster.”
Andy Deng
Director of Biologics @ Dren Bio
Smooth gradient background transitioning from red to purple to blue
Solid navy blue background with no distinguishing features
Gradient background transitioning from deep blue to lighter blue